Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters











Database
Language
Publication year range
1.
Bioanalysis ; 10(8): 559-576, 2018 Apr 01.
Article in English | MEDLINE | ID: mdl-29701071

ABSTRACT

Ligand-binding assay (LBA) performance depends on quality reagents. Strategic reagent screening and characterization is critical to LBA development, optimization and validation. Application of advanced technologies expedites the reagent screening and assay development process. By evaluating surface plasmon resonance technology that offers high-throughput kinetic information, this article aims to provide perspectives on applying the surface plasmon resonance technology to strategic LBA critical reagent screening and characterization supported by a number of case studies from multiple biotherapeutic programs.


Subject(s)
Biological Assay/methods , Biological Therapy/methods , Surface Plasmon Resonance/methods , Humans , Ligands
2.
Bioanalysis ; 10(1): 23-33, 2018 Jan.
Article in English | MEDLINE | ID: mdl-29239666

ABSTRACT

AIM: Recombinant FGF21 analogs are under wide ranging investigations as a potential therapeutic agent for Type 2 diabetes, as well as other metabolic disorders. The endogenous FGF21 is often used as a surrogate pharmacodynamic(PD) biomarker to assess drug efficacy and safety. Results & methodology: Immunocapture was performed using a monoclonal antibody which had been generated to bind to specific domain of native FGF21 as the capture reagent. After immunocapture, enzymatic digestion was performed and a native FGF21-specific tryptic peptide was monitored using LC-MS/MS by selective reaction monitoring. CONCLUSION: We have successfully developed and validated a bioanalytical assay which provides the specificity to differentiate the endogenous FGF21 from the recombinant therapeutic agent which has nearly identical sequence to the endogenous molecule.


Subject(s)
Chromatography, Liquid/methods , Fibroblast Growth Factors/metabolism , Tandem Mass Spectrometry/methods , Humans
3.
FASEB J ; 17(15): 2308-9, 2003 Dec.
Article in English | MEDLINE | ID: mdl-14563681

ABSTRACT

Voltage-gated potassium channels formed with the cardiac subunit HERG and a polymorphic variant of MinK-related peptide 1 (MiRP1) exhibit increased susceptibility to the antibiotic sulfamethoxazole (SMX) compared with channels formed with wild-type (WT) subunits. Here the molecular bases for SMX high-affinity block are investigated. The polymorphism causes a benign T to A amino acid mutation at position 8 (T8A) that destroys an N-glycosylation site of MiRP1. In vitro disruption of glycosylation by mutagenesis or in vivo by treatment with neuraminidase is associated with increased susceptibility to SMX and to other elementary agents such as divalent cations. Defective glycosylation does not affect the ability of T8A to form stable complexes with HERG, but rather it increases drug susceptibility through structural modifications in the channel complex. We conclude that N-glycosylation may play a key role in the etiology of life-threatening arrhythmia.


Subject(s)
Cation Transport Proteins , Myocytes, Cardiac/physiology , Potassium Channels, Voltage-Gated , Potassium Channels/metabolism , Potassium Channels/physiology , Sulfamethoxazole/pharmacology , Arrhythmias, Cardiac/chemically induced , Electric Conductivity , Ether-A-Go-Go Potassium Channels , Glycosylation , Models, Biological , Myocytes, Cardiac/drug effects , Polymorphism, Single Nucleotide , Potassium Channel Blockers/pharmacology , Potassium Channels/genetics
4.
J Biol Chem ; 278(14): 12415-24, 2003 Apr 04.
Article in English | MEDLINE | ID: mdl-12533541

ABSTRACT

MinK-related peptides (MiRPs) are single transmembrane proteins that associate with mammalian voltage-gated K(+) subunits. Here we report the cloning and functional characterization of a MiRP beta-subunit, MPS-1, and of a voltage-gated pore-forming potassium subunit, KVS-1, from the nematode Caenorhabditis elegans. mps-1 is expressed in chemosensory and mechanosensory neurons and co-localizes with kvs-1 in a subset of these. Inactivation of either mps-1 or kvs-1 by RNA interference (RNAi) causes partially overlapping neuronal defects and results in broad-spectrum neuronal dysfunction, including defective chemotaxis, disrupted mechanotransduction, and impaired locomotion. Inactivation of one subunit by RNAi dramatically suppresses the expression of the partner subunit only in cells where the two proteins co-localize. Co-expression of MPS-1 and KVS-1 in mammalian cells gives rise to a potassium current distinct from the KVS-1 current. Taken together these data indicate that potassium currents constitute a basic determinant for C. elegans neuronal function and unravel a unifying principle of evolutionary significance: that potassium channels in various organisms use MiRPs to generate uniqueness of function with rich variation in the details.


Subject(s)
Caenorhabditis elegans Proteins/genetics , Caenorhabditis elegans/genetics , Neurosecretory Systems/physiology , Potassium Channels, Voltage-Gated , Potassium Channels/genetics , Amino Acid Sequence , Animals , CHO Cells , Caenorhabditis elegans Proteins/chemistry , Caenorhabditis elegans Proteins/metabolism , Cloning, Molecular , Cricetinae , Evolution, Molecular , Genetic Variation , Locomotion/physiology , Mechanotransduction, Cellular/physiology , Molecular Sequence Data , Neurons, Afferent/metabolism , Neurons, Afferent/physiology , Neurosecretory Systems/cytology , Potassium Channels/chemistry , Potassium Channels/metabolism , Protein Structure, Tertiary , Shal Potassium Channels , Transfection
SELECTION OF CITATIONS
SEARCH DETAIL